• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倍半萜内酯的应用:基于抗癌活性的癌症治疗的新途径。

Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity.

机构信息

Department of Clinical Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical sciences, Tehran, Iran.

出版信息

Biomed Pharmacother. 2018 Oct;106:239-246. doi: 10.1016/j.biopha.2018.06.131. Epub 2018 Jun 28.

DOI:10.1016/j.biopha.2018.06.131
PMID:29966966
Abstract

Cancer is one of the most dangerous diseases that are rapidly increasing globally. After heart disease, it is the second leading cause of death, accounting for seven million deaths each year. Chemotherapy is the use of cytotoxic drugs on cancer cells. But the use of common chemotherapy drugs poses a problem due their high side effects and low efficacy. As a result, efforts are on to find new potent compounds with low side effects. The compounds extracted from plants have been studied in this regard due to their prevalence. Sesquiterpene lactones are a group of natural compounds that were first detected in Asteraceae dark plants. These compounds exercise their effects by reacting with functional groups available on proteins and enzymes, especially the thiol group. Owing to the high side effects as an antitumor synthetic drugs, efforts are being made to find drugs with high efficiency and low side effects. Their high structural ranges have attracted the attention of many researchers as a potential source of new anticancer drugs.

摘要

癌症是一种在全球迅速增长的最危险疾病之一。心脏病之后,它是第二大死亡原因,每年导致 700 万人死亡。化疗是使用细胞毒性药物治疗癌细胞。但是,由于普通化疗药物的副作用高、疗效低,因此使用它们存在问题。因此,人们正在努力寻找具有低副作用的新型有效化合物。由于其普遍性,已经在这方面研究了从植物中提取的化合物。倍半萜内酯是一组天然化合物,最初在菊科深色植物中被检测到。这些化合物通过与蛋白质和酶上可用的功能基团(特别是巯基)反应来发挥作用。由于作为抗肿瘤合成药物的高副作用,人们正在努力寻找高效低副作用的药物。它们的高结构范围引起了许多研究人员的关注,认为它们是潜在的新型抗癌药物的来源。

相似文献

1
Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity.倍半萜内酯的应用:基于抗癌活性的癌症治疗的新途径。
Biomed Pharmacother. 2018 Oct;106:239-246. doi: 10.1016/j.biopha.2018.06.131. Epub 2018 Jun 28.
2
The role of oxidative stress in anticancer activity of sesquiterpene lactones.氧化应激在倍半萜内酯抗癌活性中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2015 May;388(5):477-86. doi: 10.1007/s00210-015-1096-3. Epub 2015 Feb 6.
3
Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.从植物源倍半萜内酯开发抗癌剂
Curr Med Chem. 2016;23(23):2397-420. doi: 10.2174/0929867323666160510123255.
4
Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.倍半萜内酯的抗癌潜力:生物活性与分子机制
Curr Med Chem Anticancer Agents. 2005 May;5(3):239-49. doi: 10.2174/1568011053765976.
5
What made sesquiterpene lactones reach cancer clinical trials?是什么使得倍半萜内酯进入癌症临床试验?
Drug Discov Today. 2010 Aug;15(15-16):668-78. doi: 10.1016/j.drudis.2010.06.002. Epub 2010 Jun 9.
6
Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide.倍半萜内酯类化合物作为癌症治疗多靶点药物的研究进展:以小白菊内酯为例。
Anticancer Drugs. 2012 Oct;23(9):883-96. doi: 10.1097/CAD.0b013e328356cad9.
7
Recent Advances on Cytotoxic Sesquiterpene Lactones.细胞毒性倍半萜内酯的最新进展。
Curr Pharm Des. 2018;24(36):4355-4361. doi: 10.2174/1381612825666190119114323.
8
Deoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways.脱氧地胆草素和异脱氧地胆草素作为具有多种信号通路作用的潜在抗癌剂。
Molecules. 2017 Jun 21;22(6):1013. doi: 10.3390/molecules22061013.
9
Structure-Activity Relationships of Cytotoxic Lactones as Inhibitors and Mechanisms of Action.细胞毒性内酯作为抑制剂的结构-活性关系及其作用机制。
Curr Drug Discov Technol. 2020;17(2):166-182. doi: 10.2174/1570163816666190101113434.
10
A new elemanolide sesquiterpene lactone from Elephantopus scaber.一种从地胆草中分离得到的新型榄烷型倍半萜内酯。
J Asian Nat Prod Res. 2008 May-Jun;10(5-6):403-7. doi: 10.1080/10286020801966526.

引用本文的文献

1
Flavonoids and Sesquiterpene Lactones from (Arnica-Do-Cerrado) and Their In Vitro Effects on Multiple Myeloma and Acute Myeloid Leukemia.来自(巴西草原山金车)的黄酮类化合物和倍半萜内酯及其对多发性骨髓瘤和急性髓系白血病的体外作用。
Metabolites. 2025 Aug 9;15(8):542. doi: 10.3390/metabo15080542.
2
Exploration of the anticancer efficacy of a novel 1,3-thiazole analog in an ehrlich ascites carcinoma model: and insights into hepatorenal protective potentials the modulation of apoptosis, oxidative stress and inflammation.新型1,3-噻唑类似物在艾氏腹水癌模型中的抗癌疗效探索:以及对肝肾保护潜力、细胞凋亡、氧化应激和炎症调节的见解。
RSC Adv. 2025 Jun 13;15(25):20143-20167. doi: 10.1039/d5ra01014d. eCollection 2025 Jun 10.
3
The Cytotoxic Activity of Secondary Metabolites from Marine-Derived spp.: A Review (2018-2024).
海洋来源的[具体物种]次生代谢产物的细胞毒性活性综述(2018 - 2024年)
Mar Drugs. 2025 Apr 30;23(5):197. doi: 10.3390/md23050197.
4
Exploring the Ca signaling and cytotoxicity induced by the alantolactone in breast cancer cells and its potential implications in treatment using the Ca chelating agent BAPTA-AM.探讨土木香内酯在乳腺癌细胞中诱导的钙信号传导和细胞毒性及其在使用钙螯合剂BAPTA-AM进行治疗中的潜在意义。
Toxicol Res (Camb). 2025 May 9;14(3):tfaf044. doi: 10.1093/toxres/tfaf044. eCollection 2025 Jun.
5
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways.天然倍半萜内酯的研究进展:通过调节关键信号通路克服癌症耐药性
Cancer Drug Resist. 2025 Mar 24;8:13. doi: 10.20517/cdr.2024.178. eCollection 2025.
6
Cynaropicrin Induces Reactive Oxygen Species-Dependent Paraptosis-Like Cell Death in Human Liver Cancer Cells.菜蓟苦素诱导人肝癌细胞中依赖活性氧的类副凋亡样细胞死亡。
Biomol Ther (Seoul). 2025 May 1;33(3):470-482. doi: 10.4062/biomolther.2025.011. Epub 2025 Apr 4.
7
Investigation of the sensitivity of human A549 cells to paclitaxel and sesquiterpene lactone alantolactone via apoptosis induction.通过诱导细胞凋亡研究人A549细胞对紫杉醇和倍半萜内酯土木香内酯的敏感性。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 28. doi: 10.1007/s00210-025-03947-w.
8
Quantitative Proteomics and Molecular Mechanisms of Non-Hodgkin Lymphoma Mice Treated with Incomptine A, Part II.茵可停A治疗非霍奇金淋巴瘤小鼠的定量蛋白质组学及分子机制,第二部分
Pharmaceuticals (Basel). 2025 Feb 11;18(2):242. doi: 10.3390/ph18020242.
9
Understanding the Molecular Mechanisms of Incomptine A in Treating Non-Hodgkin Lymphoma Associated with U-937 Cells: Bioinformatics Approaches, Part I.了解茵芋碱A治疗与U-937细胞相关的非霍奇金淋巴瘤的分子机制:生物信息学方法,第一部分。
Pharmaceuticals (Basel). 2024 Dec 24;18(1):5. doi: 10.3390/ph18010005.
10
Unveiling Drimenol: A Phytochemical with Multifaceted Bioactivities.揭秘地锦草醇:一种具有多方面生物活性的植物化学物质。
Plants (Basel). 2024 Sep 5;13(17):2492. doi: 10.3390/plants13172492.